|
|
|
Volumn 12, Issue 11 A, 1998, Pages 381-386
|
|
Incorporating new modalities into practice guidelines: Platelet growth factors
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
PLATELET DERIVED GROWTH FACTOR RECEPTOR;
RECOMBINANT INTERLEUKIN 11;
BLEEDING;
CANCER CHEMOTHERAPY;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
EDEMA;
EVIDENCE BASED MEDICINE;
HEART ATRIUM ARRHYTHMIA;
HUMAN;
LYMPHOMA;
PRACTICE GUIDELINE;
SOLID TUMOR;
TACHYCARDIA;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
TREATMENT INDICATION;
TREATMENT PLANNING;
ANTINEOPLASTIC AGENTS;
HUMANS;
INTERLEUKIN-11;
NEOPLASMS;
PRACTICE GUIDELINES;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
|
EID: 0032408009
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (15)
|
